Gray_Eagle_V2-logo

Assessing Cancer Risks of PFOA and PFOS: IARC's Latest Findings on Persistent Chemicals

The International Agency for Research on Cancer (IARC) recently evaluated PFOA and PFOS, two highly persistent and widely used PFAS chemicals, assessing their cancer risks based on new and existing data. PFOA, linked to kidney and testicular cancers, has been classified as carcinogenic (Group 1), highlighting its serious health concerns, particularly for those exposed through contaminated water or occupational settings. PFOS, used similarly in firefighting foams and consumer goods, is considered possibly carcinogenic (Group 2B), with some evidence suggesting risks for cancer. The findings underline concerns about prolonged environmental exposure, as these chemicals accumulate in the body over time and remain in the environment for decades.

For a comprehensive look, read IARC’s detailed report in The Lancet Oncology here.


Disclaimers: Paid advertisement for legal services

While this firm maintains joint responsibility, cases of this type are referred to other attorneys for principal responsibility. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers. Prior results do not guarantee a similar outcome. Anyone considering a lawyer should independently investigate the lawyer’s credentials and ability, and not rely upon advertisements or self-proclaimed expertise. The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers. Past results do not guarantee a similar outcome in current or future cases. FREE BACKGROUND INFORMATION AVAILABLE UPON REQUEST.

© Copyright – 2025 | www.Florian.Law | All Rights Reserved

Site Policy & Terms of Use | Medical Record Release | Retainer Agreement